Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis
Journal of Medical Cases · 2026-11 · 17 (11) · 621-627
DOI: 10.14740/jmc5381 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Cases, 2026-11. Verfasst von Shreya Shambhavi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers Health/Community Medical Center, Toms River, NJ, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers Health/Community Medical Center, Toms River, NJ, USA.
Zitieren
APA
Shambhavi, S., Joy, A. A., Wilk, E., & Shah, C. (2026). Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis. Journal of Medical Cases, 17(11), 621-627. https://doi.org/10.14740/jmc5381
Vancouver
Shambhavi S, Joy AA, Wilk E, Shah C. Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis. Journal of Medical Cases. 2026;17(11):621-627. doi:10.14740/jmc5381
BibTeX
@article{Shambhavi2026,
author = {Shambhavi, Shreya and Joy, Aksa Alina and Wilk, Emilia and Shah, Chirag},
title = {Beyond Steroids: Mycophenolate Mofetil Dosing in Immune Checkpoint Inhibitor-Mediated Hepatitis},
journal = {Journal of Medical Cases},
year = {2026},
volume = {17},
number = {11},
pages = {621--627},
doi = {10.14740/jmc5381}
}
EUVIMED